vestarВестник аритмологииJournal of Arrhythmology1561-86412658-7327НАО «Инкарт»vestar-795Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL ARTICLESОСТИАЛЬНАЯ АБЛАЦИЯ ЛЕГОЧНЫХ ВЕН У ПАЦИЕНТОВ C РАЗНЫМИ ФОРМАМИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙOSTIAL ABLATION OF PULMONARY VEINS IN PATIENTS WITH DIFFERENT TYPES OF ATRIAL FIBRILLATIONЛебедевД. С.LebedevD. S.

Санкт-Петербург

МарининВ. А.MarininV. A.

Санкт-Петербург

ОршанскаяВ. С.OrshanskayaV. S.

Санкт-Петербург

Санкт-Петербургский ГМУ им. акад. И.П.Павлова; Санкт-Петербургская ГМА им. И.И.Мечникова; городская многопрофильная больница №2Russian Federation2006121020200453541Copyright © Лебедев Д.С., Маринин В.А., Оршанская В.С., 20202020Лебедев Д.С., Маринин В.А., Оршанская В.С.Lebedev D.S., Marinin V.A., Orshanskaya V.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vestar.elpub.ru/jour/article/view/795

C целью оценки безопасности и эффективности остиалъной аблации легочных вену пациентов с различными формами фибрилляции предсердий в исследование включены 86 пациентов; основную группу составили 43 пациента, которым выполнено оперативное вмешательство, контрольную - 43 пациента которым была назначена антиаритмическая терапия и непрямые антикоагулянты.

То assess the safety and effectiveness o f ostial ablation ofpulmonary veins in patients with different types o f atrial fibrillation, eighty-six patients were recruited for the study; the study group consisted o f 43 patients after the ablative procedure, the control group included 43 patients treated with antiarrhythmics and indirect anticoagulants.

фибрилляция предсердийлевое предсердиелегочные веныангиопульмонографиярадиочастотная катетерная аблацияантиаритмическая терапиявариабельность сердечного ритмаatrial fibrillationleft atriumpulmonary veinsangiopulmonographyradiofrequency catheter ablationantiarrhythmic treatmentheart rate variabilityReferencesКушаковский М.С. Фибрилляция предсердий. ИКФ, Фолиант, СПб., 1999Кушаковский М.С. Фибрилляция предсердий. ИКФ, Фолиант, СПб., 1999Подлесов А.М. Бойцов С. А., Егоров Д.Ф. СПБ 2001, стр. 8-10.Подлесов А.М. Бойцов С. А., Егоров Д.Ф. СПБ 2001, стр. 8-10.Feinberg W.M., Blackshear J.L., Laupacis A. et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995; 155:469-73Feinberg W.M., Blackshear J.L., Laupacis A. et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995; 155:469-73Benjamin E.J., Wolf RA. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998,98:946-952.Benjamin E.J., Wolf RA. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998,98:946-952.Levy S. et al. Atrial fibrillation: current knowledge and recommendations for management. Eur. Heart J. 1998; 19: 1294-1302.Levy S. et al. Atrial fibrillation: current knowledge and recommendations for management. Eur. Heart J. 1998; 19: 1294-1302.Bigger J.T. Epidemiological and mechanistic studies of atrial fibrillation as a basis of treatment strategies. Circulation 1998; 98:943-945.Bigger J.T. Epidemiological and mechanistic studies of atrial fibrillation as a basis of treatment strategies. Circulation 1998; 98:943-945.Brand F. N., Abbot R.D. et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham study. JAMA 1985; 254: 3449-53.Brand F. N., Abbot R.D. et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham study. JAMA 1985; 254: 3449-53.Kannel W.B., Abbot R.D. et al. Epidemiologic futures of chronic atrial fibrillation: the Framingham study. N. Engl. J. Med. 1982;306:1018-22.Kannel W.B., Abbot R.D. et al. Epidemiologic futures of chronic atrial fibrillation: the Framingham study. N. Engl. J. Med. 1982;306:1018-22.Hart R.G. et al. Atrial fibrillation and strokeHart R.G. et al. Atrial fibrillation and strokePage R., Tilsch T.W. Asymptomatic or “Silent” Atrial Fibrillation. Circulation 2003; 107; 1141-1145.Page R., Tilsch T.W. Asymptomatic or “Silent” Atrial Fibrillation. Circulation 2003; 107; 1141-1145.Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002; 415; 219-226Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002; 415; 219-226Allessie M.A. et al. Experimental evaluation of Moe’s wavelet hypothesis of atrial fibrillation. In Zipes D.P Cardiac Electrophysiology and Arrhythmias Orlando, WB Saunders; 1985:265-275.Allessie M.A. et al. Experimental evaluation of Moe’s wavelet hypothesis of atrial fibrillation. In Zipes D.P Cardiac Electrophysiology and Arrhythmias Orlando, WB Saunders; 1985:265-275.Alessie M.A., Boyden RA. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103:769-777.Alessie M.A., Boyden RA. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103:769-777.Wijffles M.C. et al. Atrial fibrillation beget atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.Wijffles M.C. et al. Atrial fibrillation beget atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.Arora R. Verheule S., Scott L. et al. Arrytmogenic Substrate of the Pulmonary Veins Assessed by High-Resolution Optical Mapping. Circulation 2003; 107; 1816-1821.Arora R. Verheule S., Scott L. et al. Arrytmogenic Substrate of the Pulmonary Veins Assessed by High-Resolution Optical Mapping. Circulation 2003; 107; 1816-1821.Tsai C. F. Pulmonary vein ablation: role in prevention atrial fibrillation. Current Opinion in Cardiology. Lippicott W&W2003; 18:39-46.Tsai C. F. Pulmonary vein ablation: role in prevention atrial fibrillation. Current Opinion in Cardiology. Lippicott W&W2003; 18:39-46.Lin W. S. Catheter ablation of paroxysmal atrial fibrillation initiated by non pulmonary vein ectopy. Circulation. 2003;107:3176-3183.Lin W. S. Catheter ablation of paroxysmal atrial fibrillation initiated by non pulmonary vein ectopy. Circulation. 2003;107:3176-3183.Scheinman M.M., Morady F. Nonfarmacological Approaches to Atrial Fibrillation. Circulation. 2001; 103; 21202125.Scheinman M.M., Morady F. Nonfarmacological Approaches to Atrial Fibrillation. Circulation. 2001; 103; 21202125.Blum N. A. et al. Development of the cardiac condaction tissue in human embryos using HNK-I antigen expression: possible relevans for understanding of abnormal atrial automaticy. Circulation. 1999; 99:800-806.Blum N. A. et al. Development of the cardiac condaction tissue in human embryos using HNK-I antigen expression: possible relevans for understanding of abnormal atrial automaticy. Circulation. 1999; 99:800-806.Kantachuvessiri A. et al. Pulmonary veins: Preferred site for catheter ablation of atrial fibrillation. Heart and lung.2002; 3:271-278.Kantachuvessiri A. et al. Pulmonary veins: Preferred site for catheter ablation of atrial fibrillation. Heart and lung.2002; 3:271-278.Chen S.A., Hsieh M.N., Tai T.C. et al. Initiation of atrial fibrillationby ectopic beats originating from the pulmonary veins. Circulation 1999; 100:1879-1866.Chen S.A., Hsieh M.N., Tai T.C. et al. Initiation of atrial fibrillationby ectopic beats originating from the pulmonary veins. Circulation 1999; 100:1879-1866.Page L. et al. Beta-blokers for atrial fibrillation: must we consider asymptomatic arrhythmias ? JACC 2000; 36: 147-150.Page L. et al. Beta-blokers for atrial fibrillation: must we consider asymptomatic arrhythmias ? JACC 2000; 36: 147-150.Haissaguerre M. et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998; 339: 659-666.Haissaguerre M. et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998; 339: 659-666.Haissaguerre M. et al. Electrophysiological end point for cateter ablation of atrial fibrillation initiated from multiple pulmonary vein foci. Circulation. 2000; 101:1409-1417.Haissaguerre M. et al. Electrophysiological end point for cateter ablation of atrial fibrillation initiated from multiple pulmonary vein foci. Circulation. 2000; 101:1409-1417.Lau C.P, Tse H.F. et al. Defibrillation-gided radiofrequency ablation of AF secondary to atrial focus. JACC 1999; 33: 1217-1226.Lau C.P, Tse H.F. et al. Defibrillation-gided radiofrequency ablation of AF secondary to atrial focus. JACC 1999; 33: 1217-1226.Stable G., Turco P, La Rocca V. et al. Is pulmonary vein isolation nessesery for curing atrial fibrillation ? Circulation. 2003;108:657-660.Stable G., Turco P, La Rocca V. et al. Is pulmonary vein isolation nessesery for curing atrial fibrillation ? Circulation. 2003;108:657-660.Hwang C., Chen S.A. et al. Idiopatic paroxysmal AF induced by a focal discharge mechanism in the left superior pulmonary vein: possible role of the ligament Marshall. J. Cardiovasc. Electrophysiol. 1999; 10: 636-648.Hwang C., Chen S.A. et al. Idiopatic paroxysmal AF induced by a focal discharge mechanism in the left superior pulmonary vein: possible role of the ligament Marshall. J. Cardiovasc. Electrophysiol. 1999; 10: 636-648.Chen S .A., Tai S .T. Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats J. Cardio vase. Electrophysiol. 2000; 11:218-227.Chen S .A., Tai S .T. Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats J. Cardio vase. Electrophysiol. 2000; 11:218-227.Pappone C. et al. Circumferential radiofrequency ablation of pulmonary vein ostia. A new anatomic approach for curing atrial fibrillation. Circulation. 2000; 102:2619-2628.Pappone C. et al. Circumferential radiofrequency ablation of pulmonary vein ostia. A new anatomic approach for curing atrial fibrillation. Circulation. 2000; 102:2619-2628.Pappone C. et al. Atrial electroanatomic remodeling after circumferential radiofrequency vein ablation. Efficacy of the anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001; 104:2539-2544.Pappone C. et al. Atrial electroanatomic remodeling after circumferential radiofrequency vein ablation. Efficacy of the anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001; 104:2539-2544.Oral H., Knight B.P.et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105:1077-1081.Oral H., Knight B.P.et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105:1077-1081.Pappone C. The Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation. J Cardiovasc Electrophysiol 15(10): 1226-1230,2004Pappone C. The Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation. J Cardiovasc Electrophysiol 15(10): 1226-1230,2004Lloyd-Jones DM, Wang TJ, Leip E, et al. Lifetime risk for development of atrial fibrillation. Circulation 2004; 110:10421046.Lloyd-Jones DM, Wang TJ, Leip E, et al. Lifetime risk for development of atrial fibrillation. Circulation 2004; 110:10421046.Fisher J.D.; Spinelli M.A.; Mookherj ее D. Atrial Fibrillation Ablation: Reaching the Mainstream Pacing Clin Electrophysiol. 2006; 29(5): 523-537.Fisher J.D.; Spinelli M.A.; Mookherj ее D. Atrial Fibrillation Ablation: Reaching the Mainstream Pacing Clin Electrophysiol. 2006; 29(5): 523-537.Karch MR; Zrenner B; Deisenhofer I. et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 2005; 111(22): 2875-80.Karch MR; Zrenner B; Deisenhofer I. et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 2005; 111(22): 2875-80.Flaker G. C.; Belew K. et al. Asymptomatic Atrial Fibrillation: Demographic Features and Prognostic Information From the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study Am Heart J. 2005; 149(4):657-663.Flaker G. C.; Belew K. et al. Asymptomatic Atrial Fibrillation: Demographic Features and Prognostic Information From the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study Am Heart J. 2005; 149(4):657-663.Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation 2005;112:1214-1222.Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation 2005;112:1214-1222.Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111:1100-1105.Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111:1100-1105.Nilsson B.; Chen X.; Pehrson S.; Hilden J.; Svendsen J.H. Increased resting heart rate following radiofrequency catheter ablation for atrial fibrillation. Europace. 2005; 7(5):415-20.Nilsson B.; Chen X.; Pehrson S.; Hilden J.; Svendsen J.H. Increased resting heart rate following radiofrequency catheter ablation for atrial fibrillation. Europace. 2005; 7(5):415-20.Pappone C., Santinelli V. et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004: 109(3)327-34.Pappone C., Santinelli V. et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004: 109(3)327-34.

The authors declare that there are no conflicts of interest present.